HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Genprex (NASDAQ:GNPX) and maintained a $10 price target, as stated by analyst Yi Chen.
May 17, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Genprex (NASDAQ:GNPX) and maintained a $10 price target, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and could lead to a short-term increase in GNPX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100